Skip to content

Insider · CIK 0001721412

Or Eisenberg

cfoofficer

Files at NRSN (NeuroSense Therapeutics Ltd.). First filing Jun 17, 2026, latest Jun 17, 2026.

In brief

Or Eisenberg files SEC Form 4 as CFO at NRSN (NeuroSense Therapeutics Ltd.). Since Jun 17, 2026, Or Eisenberg has reported 1 open-market buy worth $200k and 0 open-market sells worth $0, the latest filed on Jun 17, 2026.

A track record needs three past buys with six months of prices behind them; Or Eisenberg has 0, so none is measured yet.

The newest scored trade: bought $200k of NRSN on Jun 16, 2026, filed Jun 17, 2026, scored 63 (notable). In the last 12 months: 1 buy worth $200k and 0 sells worth $0.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$200k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

NRSN: NeuroSense Therapeutics Ltd.

NRSNOct 9, 2026 · close 3.66

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
63Notable
NRSNbuy 2
NeuroSense Therapeutics Ltd.
$200k
250,000 shares
+20%+2% from low-71% from high

Transactions

Every row this insider has filed, 2 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 16, 2026NRSN
NeuroSense Therapeutics Ltd.
POpen-market purchase
Ordinary Shares
+250,000$0.80$200k1,504,050Jun 17, 2026
Mar 26, 2026NRSN
NeuroSense Therapeutics Ltd.
AGrant or award
Ordinary Shares
+200,000$0.00$01,254,050Apr 1, 2026

Questions about Or Eisenberg

Answered from the filings on this page, as of the latest one.

Is Or Eisenberg buying or selling?

In the last 12 months Or Eisenberg reported 1 open-market buy worth $200k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $200k of NRSN on Jun 16, 2026. Grants, option exercises and tax withholding are not counted.

How did Or Eisenberg's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Or Eisenberg has 0.

Where does Or Eisenberg file Form 4?

Or Eisenberg has filed Form 4 at NRSN (NeuroSense Therapeutics Ltd.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Or Eisenberg: insider trades and track record | InsiderTell